Follow
Multiple Myeloma
Multiple Myeloma: is a cancer that forms in certain types of white blood cells called plasma cells. Plasma cells help you fight off infections by creating and making antibodies that recognize and attack germs in the body. Multiple myeloma causes cancer cells to grow in the bone marrow, where they eventually push out the healthy cells. The cancer cells produce abnormal proteins that can cause complications.
-
MAR 06, 2024Health & Medicine
Gone are the days when therapies for medical conditions were based solely on statistical data of the broad population, l ...Sponsored By: ESSERT RoboticsJUL 17, 2023Drug Discovery & DevelopmentIntroduction Antibodies are the ideal therapeutic biomolecules due to their ability to bind to a variety of targets with ...MAR 29, 2023Clinical & Molecular DX
A new review paper, which takes a broad view of research developments in a field, has suggested that the circadian rhyth ...Written By: Carmen LeitchJAN 17, 2023Clinical & Molecular DX
When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years ...Sponsored By: Roche Sequencing and Life ScienceDEC 30, 2022Cancer
As we near the end of 2022, and enter our fourth year of facing COVID-19 (so named because of it’s emergence in 20 ...Written By: Katie KokolusDEC 26, 2022Immunology
Almost every patient who gets myeloma and is treated with a standard therapy also experiences relapse. But researchers h ...Written By: Carmen LeitchSEP 13, 2022Cancer
Introduction Cancer is the second leading cause of death globally. According to estimates from the American Cancer Socie ...Sponsored By: Sino BiologicalJUL 11, 2022Cancer
Chimeric antigen receptor (CAR) T Cell therapy has emerged as a promising immunotherapeutic approach to treat blood canc ...Written By: Katie KokolusJAN 20, 2022Immunology
Scientists studying a neglected tropical disease have made a chance discovery—a promising therapeutic targe ...Written By: Tara FernandesDEC 16, 2021Cancer
The incidence of various cancers, including multiple myeloma, colorectal, kidney, and pancreatic cancer, is steadily&nbs ...Written By: Katie KokolusAPR 11, 2021Genetics & Genomics
Vaccines are mostly known as tools to prevent illness. But cancer vaccines are a bit different, and aim to treat existin ...Written By: Carmen LeitchFEB 23, 2021Immunology
University of Limerick researchers have discovered direct links between the immune system, specific personality traits, ...Written By: Tara FernandesFEB 17, 2021Cancer
New research published today in the American Association for Cancer Research journal Blood Cancer Discovery propose ...Written By: Kathryn DeMuth SullivanDEC 04, 2020Drug Discovery & Development
Injecting the immune-boosting drug ‘teclistamab’ was found to be safe and effective in patients with relapse ...Written By: Nouran AminJUL 16, 2020Immunology
Kristen Radford, a professor at Australia’s University of Queensland is among a scientific research team developin ...Written By: Tara FernandesOCT 03, 2019Cancer
Research published recently in Cell Stem Cell details the results from a new anticancer immunotherapy that uses invarian ...Written By: Kathryn DeMuth SullivanAUG 25, 2019Drug Discovery & Development
According to the findings of a clinical trial, scientists at Mt. Sinai have found a new therapeutic effective for p ...Written By: Nouran AminFEB 04, 2019Cancer
With all of these "new and improved" methods to treat cancer, such as immuno-based, using nanotechnology, to g ...Written By: Amy LoriauxFEB 04, 2019Cancer
In a recent report out of The Lancet: Public Health, published by Dr. Ahmedin Jemal, Ph.D., and colleagues fro ...Written By: Amy LoriauxAUG 07, 2018Cancer
A group of US researchers have identified CD13 in certain subtypes of B-cell neoplasms, thereby aiding in a more detaile ...Written By: Mauri BrueggemanAUG 07, 2018Cancer
Targeted therapy for Bcl-2 may be helpful in more than the two lymphoma diagnoses that were recently approved by the FDA ...Written By: Mauri BrueggemanJUL 03, 2018Cancer
New changes in myeloid classification help to outline a new category of AML which develops as a result of hereditary mut ...Written By: Mauri BrueggemanJUN 05, 2018Cancer
The NCI-MATCH Phase II Clinical Trial is evaluating results of cancer treatments administered based on genetic profiles ...Written By: Mauri Brueggeman
MAR 06, 2024
Health & Medicine
Gone are the days when therapies for medical conditions were based solely on statistical data of the broad population, l
...
Sponsored By:
ESSERT Robotics
JUL 17, 2023
Drug Discovery & Development
Introduction Antibodies are the ideal therapeutic biomolecules due to their ability to bind to a variety of targets with
...
MAR 29, 2023
Clinical & Molecular DX
A new review paper, which takes a broad view of research developments in a field, has suggested that the circadian rhyth
...
Written By:
Carmen Leitch
JAN 17, 2023
Clinical & Molecular DX
When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years
...
Sponsored By:
Roche Sequencing and Life Science
DEC 30, 2022
Cancer
As we near the end of 2022, and enter our fourth year of facing COVID-19 (so named because of it’s emergence in 20
...
Written By:
Katie Kokolus
DEC 26, 2022
Immunology
Almost every patient who gets myeloma and is treated with a standard therapy also experiences relapse. But researchers h
...
Written By:
Carmen Leitch
SEP 13, 2022
Cancer
Introduction Cancer is the second leading cause of death globally. According to estimates from the American Cancer Socie
...
Sponsored By:
Sino Biological
JUL 11, 2022
Cancer
Chimeric antigen receptor (CAR) T Cell therapy has emerged as a promising immunotherapeutic approach to treat blood canc
...
Written By:
Katie Kokolus
JAN 20, 2022
Immunology
Scientists studying a neglected tropical disease have made a chance discovery—a promising therapeutic targe
...
Written By:
Tara Fernandes
DEC 16, 2021
Cancer
The incidence of various cancers, including multiple myeloma, colorectal, kidney, and pancreatic cancer, is steadily&nbs
...
Written By:
Katie Kokolus
APR 11, 2021
Genetics & Genomics
Vaccines are mostly known as tools to prevent illness. But cancer vaccines are a bit different, and aim to treat existin
...
Written By:
Carmen Leitch
FEB 23, 2021
Immunology
University of Limerick researchers have discovered direct links between the immune system, specific personality traits,
...
Written By:
Tara Fernandes
FEB 17, 2021
Cancer
New research published today in the American Association for Cancer Research journal Blood Cancer Discovery propose
...
Written By:
Kathryn DeMuth Sullivan
DEC 04, 2020
Drug Discovery & Development
Injecting the immune-boosting drug ‘teclistamab’ was found to be safe and effective in patients with relapse
...
Written By:
Nouran Amin
JUL 16, 2020
Immunology
Kristen Radford, a professor at Australia’s University of Queensland is among a scientific research team developin
...
Written By:
Tara Fernandes
OCT 03, 2019
Cancer
Research published recently in Cell Stem Cell details the results from a new anticancer immunotherapy that uses invarian
...
Written By:
Kathryn DeMuth Sullivan
AUG 25, 2019
Drug Discovery & Development
According to the findings of a clinical trial, scientists at Mt. Sinai have found a new therapeutic effective for p
...
Written By:
Nouran Amin
FEB 04, 2019
Cancer
With all of these "new and improved" methods to treat cancer, such as immuno-based, using nanotechnology, to g
...
Written By:
Amy Loriaux
FEB 04, 2019
Cancer
In a recent report out of The Lancet: Public Health, published by Dr. Ahmedin Jemal, Ph.D., and colleagues fro
...
Written By:
Amy Loriaux
AUG 07, 2018
Cancer
A group of US researchers have identified CD13 in certain subtypes of B-cell neoplasms, thereby aiding in a more detaile
...
Written By:
Mauri Brueggeman
AUG 07, 2018
Cancer
Targeted therapy for Bcl-2 may be helpful in more than the two lymphoma diagnoses that were recently approved by the FDA
...
Written By:
Mauri Brueggeman
JUL 03, 2018
Cancer
New changes in myeloid classification help to outline a new category of AML which develops as a result of hereditary mut
...
Written By:
Mauri Brueggeman
JUN 05, 2018
Cancer
The NCI-MATCH Phase II Clinical Trial is evaluating results of cancer treatments administered based on genetic profiles
...
Written By:
Mauri Brueggeman